Sugi Predict

Sugi Predict / Compounds / SCHEMBL2466643

SCHEMBL2466643

SCHEMBL2466643

O=C(O)CCc1ccc(-c2ccccc2)o1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 1.00
▸ MAPT P10636 5/20 1.00
▸ PKM P14618 4/20 1.00
▸ HSD17B10 Q99714 3/20 1.00
▸ HTT P42858 2/20 1.00
▸ TDP1 Q9NUW8 2/20 1.00
▸ POLB P06746 1/20 1.00
▸ KDM4E B2RXH2 5/20 0.73
▸ HPGD P15428 5/20 0.73
▸ CYP2C19 P33261 3/20 0.73
▸ TSHR P16473 2/20 0.73
▸ NPSR1 Q6W5P4 2/20 0.73
▸ GFER P55789 1/20 0.73
▸ PPARG P37231 1/20 0.73
▸ NCOA2 Q15596 1/20 0.73
▸ RXFP1 Q9HBX9 1/20 0.73
▸ NCOR2 Q9Y618 1/20 0.73
▸ DDAH1 O94760 1/20 0.73
▸ CYP1A2 P05177 1/20 0.73
▸ SMN1; SMN2 Q16637 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28429884 0.91 ALDH1A1 (0.84) ALDH1A1MAPTPKMHSD17B10HTT
SCHEMBL14654432 0.86 ALDH1A1 (0.76) ALDH1A1MAPTPKMHSD17B10HTT
SCHEMBL16921274 0.85 ALDH1A1 (0.73) ALDH1A1MAPTPKMHSD17B10HTT
SCHEMBL15213964 0.85 ALDH1A1 (1.00) ALDH1A1MAPTPKMHSD17B10HTT
SCHEMBL9208149 0.81 ALDH1A1 (0.69) ALDH1A1MAPTPKMHSD17B10HTT
SCHEMBL11705730 0.81 ALDH1A1 (0.69) ALDH1A1MAPTPKMHSD17B10HTT
SCHEMBL18177326 0.81 ALDH1A1 (1.00) ALDH1A1MAPTPKMHSD17B10HTT
SCHEMBL17491872 0.80 ALDH1A1 (0.66) ALDH1A1MAPTPKMHSD17B10HTT
SCHEMBL9254121 0.79 ALDH1A1 (0.64) ALDH1A1MAPTPKMHSD17B10HTT
SCHEMBL7405206 0.79 ALDH1A1 (0.65) ALDH1A1MAPTPKMHSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111808011-B High penetration composition and its application 泰飞尔生物医药(苏州)有限公司 2024-02-27 — — CN disclosed
US-20230233516-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS TECHFIELDS PHARMA CO., LTD (CN) 2023-07-27 — — US disclosed
US-11541029-B2 High penetration compositions and their applications TECHFIELDS PHARMA CO., LTD. (CN) 2023-01-03 — — US disclosed
US-11478457-B2 Castration-resistant prostate cancer NUTECH VENTURES (US) 2022-10-25 — — US disclosed
CN-113636965-A High penetration composition and application thereof 于崇曦 2021-11-12 — — CN disclosed
CN-107320732-B High penetration composition and application thereof 于崇曦 2021-09-07 — — CN disclosed
CN-108191846-B High penetration composition and application thereof 于崇曦 2021-08-20 — — CN disclosed
CN-111808011-A High penetration composition and application thereof 于崇曦 2020-10-23 — — CN disclosed
CN-108191846-A High-penetration composition and its application 于崇曦 2018-06-22 — — CN disclosed
CN-107320732-A High-penetration composition and its application 于崇曦 2017-11-07 — — CN disclosed
US-9700633-B2 Conjugates of water soluble polymer-amino acid oligopeptide-drug, preparation method and use thereof JENKEM TECHNOLOGY CO., LTD., TIANJIN BRANCH (CN) 2017-07-11 — — US disclosed
WO-2016172545-A1 CASTRATION-RESISTANT PROSTATE CANCER NUTECH VENTURES (US) 2016-10-27 — — WO disclosed
US-20160310528-A1 Castration-Resistant Prostate Cancer NUTECH VENTURES 2016-10-27 — — US disclosed
US-20160310528-A1 Castration-Resistant Prostate Cancer NUTECH VENTURES 2016-10-27 — — US disclosed
US-20160310528-A1 Castration-Resistant Prostate Cancer NUTECH VENTURES 2016-10-27 — — US disclosed
US-20150359900-A1 CONJUGATES OF WATER SOLUBLE POLYMER-AMINO ACID OLIGOPEPTIDE-DRUG, PREPARATION METHOD AND USE THEREOF JENKEM TECHNOLOGY CO. LTD., TIANJIN BRANCH (CN) 2015-12-17 — — US disclosed
US-20110269689-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS PREMIER RESEARCH INTERNATIONAL, LLC 2011-11-03 — — US disclosed
EP-2370406-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS Yu, Chongxi (US) 2011-10-05 — — EP disclosed
WO-2010065936-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS YU CHONGXI (US) 2010-06-10 — — WO disclosed
US-4123529-A TREATMENT OF ASTHMA LILLY INDUSTRIES LIMITED (GB) 1978-10-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160310528-A1 Castration-Resistant Prostate Cancer UGDH, G6PD, DPYD ALDH1A1 54/4885MAPT 2722/4885PKM 1024/4885
US-20150359900-A1 CONJUGATES OF WATER SOLUBLE POLYMER-AMINO ACID OLIGOPEPTIDE-DRUG, PREPARATION METHOD AND USE THEREOF SLC7A1, NPPA, PEPD ALDH1A1 2543/4885MAPT 590/4885PKM 1852/4885
US-11478457-B2 Castration-resistant prostate cancer UGDH, G6PD, DPYD ALDH1A1 54/4885MAPT 2722/4885PKM 1024/4885
US-20110269689-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS SLC19A1, HIRA, SLC43A1 ALDH1A1 829/4885MAPT 1754/4885PKM 3739/4885
US-11541029-B2 High penetration compositions and their applications SLC19A1, HIRA, SLC43A1 ALDH1A1 829/4885MAPT 1754/4885PKM 3739/4885
US-20230233516-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS SLC5A7, SLC19A1, SLC43A1 ALDH1A1 2302/4885MAPT 2642/4885PKM 3328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.